Elevance Health, Inc. (ELV)
| Market Cap | 74.75B |
| Revenue (ttm) | 194.82B |
| Net Income (ttm) | 5.53B |
| Shares Out | 222.24M |
| EPS (ttm) | 24.39 |
| PE Ratio | 13.79 |
| Forward PE | 11.97 |
| Dividend | $6.84 (2.03%) |
| Ex-Dividend Date | Dec 5, 2025 |
| Volume | 1,563,217 |
| Open | 341.22 |
| Previous Close | 339.40 |
| Day's Range | 334.53 - 342.23 |
| 52-Week Range | 273.71 - 458.75 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | 392.47 (+16.68%) |
| Earnings Date | Oct 21, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $392.47, which is an increase of 16.68% from the latest price.
News
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery
Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation...
US health insurance premiums rose to $27,000 for families in 2025
Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other prescription drugs,...
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
MINNEAPOLIS--(BUSINESS WIRE)-- #HistoSonics--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members.
Elevance: Checking Out The Q3 Report
Elevance Health reported Q3 results, beating consensus earnings estimates. However, the beat was due to one-off items. Key focus areas include Medical Cost Ratio stabilization, 2026 premium rate re-fi...
Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q3 2025 Earnings Call October 21, 2025 8:30 AM EDT Company Participants Nathan Rich - Vice President of Investor Relations Gail Boudreaux - President, CEO & Director ...
Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs
Elevance Health Tuesday said third quarter net income rose to nearly $1.2 billion despite rising costs in its government subsidized health insurance plans.
Elevance Health Quarterly Profit Climbs as Memberships Slip
Elevance Health logged higher profit in the third quarter as revenue rose, despite a slip in overall memberships.
Elevance beats quarterly profit estimates as medical costs remained in check
Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check.
Elevance Health Reports Third Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across...
Managed Care Insurers Trading Down Ahead Of Earnings Season
US managed care insurers were trading down this week ahead of earnings season as the release of Medicare ratings and federal tax credit uncertainty appeared to weigh on stock prices. The S&P 500 and S...
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV)...
Many Large U.S. Insurers Trade In The Green As Shutdown Continues
Share of only a handful of large-cap US insurers finished the week in negative territory, while the majority of insurers were either flat or saw gains as Congress failed to reach an agreement to keep ...
Zhang: META at "Good Entry Point," ELV Turnaround Intact, Bearish on CZR
@OptionsPlay's Tony Zhang says he's been "bullish for quite some time" on Meta Platforms (META) due to how it uses A.I. to boost advertising revenue.
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review the...
Elevance Health: Undervalued Defensive Giant With Long-Term Upside
Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line c...
Northwest Middle School Unveils New Weight Room in Partnership with Elevance Health and Impact Fitness Foundation
INDIANAPOLIS--(BUSINESS WIRE)--Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership w...
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.'s (Elevance Health) (headquartered in Indianapolis, IN) newly...
Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation
ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opport...
Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States
INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding w...
Top 15 High-Growth Dividend Stocks For September 2025
My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 1...
Elevance Health - Piggy Bank Or Headache?
Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. In...
Elevance Health loses bid to challenge US Medicare star ratings
A federal judge in Texas on Tuesday rejected Elevance Health's challenge of the U.S. government's calculation for the health insurer's star ratings for some of its government-backed Medicare plans aft...
Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care
INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) progra...
3 SWANs On Sale
Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a li...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...